- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01782417
Pilot Testing a Patient and Provider Intervention for Managing Osteoarthritis in Hispanic Adults. (PRIMO-Latino)
October 11, 2015 updated by: Duke University
Hispanics are affected by arthritis at a slightly lower age-adjusted rate compared to non-Hispanic whites and African Americans.
However, compared to other groups, Hispanics have a higher prevalence of arthritis-attributed activity limitations (primarily related to OA), are less likely to receive hip replacement independent of health care access, and are less likely to receive knee replacement.
The study is conducted to develop and test a telephone delivered intervention for the management of OA in Hispanic adults.
This study is conducted as a minority supplement to the Patient and Provider Interventions for Managing Osteoarthritis in Primary Care (PRIMO) NCT01435109 and Pro00022836.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Arthritis affects approximately 50 million adults in the United States (US), making it one of the most common causes of disability in this county.
In addition, is associated with significant physical activity limitations, increased prevalence of obesity, decreased health related quality of life, and increased health care costs.
Hispanics are affected by arthritis at a slightly lower age-adjusted rate compared to non-Hispanic whites and African Americans.
However, compared to other groups, Hispanics have a higher prevalence of arthritis-attributed activity limitations (primarily related to OA), are less likely to receive hip replacement independent of health care access, and are less likely to receive knee replacement.
In addition, there have been very few interventions to improve either medical or behavioral aspects of OA treatment recommendations among the Hispanic population.
The study will developed and test a culturally appropriate Spanish educational materials and telephone scripts for the patient- and provider-based interventions and will test the patient and provider intervention in a group of Adult Hispanics with OA.
Study Type
Interventional
Enrollment (Actual)
16
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27710
- Duke University Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Radiographic evidence of hip OA and/or radiographic evidence of or meets clinical criteria for knee OA
- Current joint (hip and/or knee) symptoms
- BMI >= 25
- Physically inactive
- Spanish speakers
Exclusion Criteria:
- Diagnosis of rheumatoid arthritis, fibromyalgia, or other systemic rheumatic disease
- Diagnosis of a motor neuron disease, Parkinson's disease, multiple sclerosis, or Paget's disease
- Diagnosis of metastatic cancer
- Hospitalized for a stroke, myocardial infarction or coronary artery revascularization in the past 3 months
- On waiting list for or planning arthroplasty
- Total joint replacement (hip or knee) surgery, other hip or knee surgery, meniscus tear (verified by MRI), or (anterior cruciate ligament) ACL tear in the past 6 months
- History of gout in hip or knee
- Quadriplegia or paraplegia
- Active diagnosis of psychosis or serious personality disorder
- Diagnosis of dementia or other memory loss condition
- Current, uncontrolled substance abuse disorder
- Severly impaired speech or hearing (patients must be able to respond to phone calls)
- No access to a telephone
- Resident in nursing home
- Serious / terminal illness as indicated by referral to hospice or palliative care
- For females: currently pregnant or planning to become pregnant
- Participating in another OA intervention of other lifestyle change study
- Other self-reported medical problem that would prohibit participation in the study
- Other health condition or personal issue judged by a study team member or primary care physician to make the patient inappropriate for study participation.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Patient and provider intervention
participants will receive a patient and provider intervention
|
Patients receive a 12-month intervention consisting of monthly phone calls focusing on exercise, weight management, and cognitive behavioral pain management; primary care providers receive patient-specific osteoarthritis information and treatment recommendations at the point of clinical care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Self-reported pain, stiffness and function.
Time Frame: baseline, 6 months and 12 months.
|
Measured by the validated Spanish version of the Western Ontario and McMasters Universities Osteoarthritis Index (WOMAC).
|
baseline, 6 months and 12 months.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Physical function
Time Frame: Baseline and 12 months
|
Short Physical Performance Test Protocol
|
Baseline and 12 months
|
|
Change in Depressive symptoms
Time Frame: Baseline and 12 months
|
Measured with the Spanish version of the Patient Health Questionnaire (PHQ-8).
|
Baseline and 12 months
|
|
Change in weight
Time Frame: Baseline and 12 months
|
measured on a standard scale
|
Baseline and 12 months
|
|
Participants perception of the intervention
Time Frame: 12 months
|
Semi structured interviews
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Kelli Allen, PhD, Duke University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2013
Primary Completion (Actual)
June 1, 2015
Study Completion (Actual)
June 1, 2015
Study Registration Dates
First Submitted
January 31, 2013
First Submitted That Met QC Criteria
January 31, 2013
First Posted (Estimate)
February 1, 2013
Study Record Updates
Last Update Posted (Estimate)
October 14, 2015
Last Update Submitted That Met QC Criteria
October 11, 2015
Last Verified
June 1, 2015
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro00022836_1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoarthritis
-
Hacettepe UniversityNot yet recruitingThumb Osteoarthritis | Trapeziometacarpal Osteoarthritis | Carpometacarpal Osteoarthritis | Thumb Basal Joint OsteoarthritisTurkey (Türkiye)
-
Sanford HealthTerminatedKnee Osteoarthritis | Hip Osteoarthritis | Shoulder Osteoarthritis | Ankle Osteoarthritis | Wrist OsteoarthritisUnited States
-
Edin MešanovićCompletedOsteoarthritis | Osteoarthritis of the Knee | Osteoarthritis of Knee | Osteoarthritis of the Knees | Osteoarthritis (OA) of the Knee | Osteoarthritis Knee | Osteoarthritis in the Knee | Osteoarthritis of Knee JointBosnia and Herzegovina
-
Hospital for Special Surgery, New YorkRoyal Infirmary of EdinburghRecruitingKnee Osteoarthritis | Hip Osteoarthritis | Shoulder OsteoarthritisUnited States, United Kingdom
-
Golden Jubilee National HospitalJohnson & Johnson; DePuy OrthopaedicsNot yet recruitingOsteoarthritis | Knee Osteoarthritis | Osteoarthritis (OA) | Osteo Arthritis | Osteoarthritis in the Knee | Osteoarthritis (Knee) | Osteo Arthritis of the KneeUnited Kingdom
-
Middlesex UniversityRecruitingOsteoarthritis | Osteoarthritis (OA) | Osteoarthritis (OA) of the Knee | Osteoarthritis (OA) of the HipUnited Kingdom
-
University of EdinburghHospital for Special Surgery, New YorkActive, not recruitingKnee Osteoarthritis | Hip Osteoarthritis | Shoulder OsteoarthritisUnited Kingdom
-
Medical University of WarsawUnknownOsteoarthritis | Knee Osteoarthritis | Hip Osteoarthritis | Glenohumeral OsteoarthritisPoland
-
Medical University of WarsawUnknownOsteoarthritis | Knee Osteoarthritis | Hip Osteoarthritis | Glenohumeral OsteoarthritisPoland
-
Istanbul University - CerrahpasaCompletedKnee Osteoarthritis | Knee Osteoarthritis (Knee OA)Turkey (Türkiye)
Clinical Trials on patient and provider intervention
-
Duke UniversityNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsCompletedOsteoarthritisUnited States
-
University of Alabama at BirminghamCompletedSickle Cell DiseaseUnited States
-
University of HawaiiAgency for Healthcare Research and Quality (AHRQ)RecruitingCancer | OncologyUnited States
-
Milton S. Hershey Medical CenterNational Cancer Institute (NCI)CompletedColorectal CancerUnited States
-
Emory UniversityNational Institute of Allergy and Infectious Diseases (NIAID)Completed
-
Harvard Pilgrim Health CareFood and Drug Administration (FDA); Duke Clinical Research Institute; Aetna,... and other collaboratorsCompletedStroke | Atrial FibrillationUnited States
-
University of California, Los AngelesNational Heart, Lung, and Blood Institute (NHLBI)Active, not recruiting
-
University of Southern CaliforniaNational Psoriasis FoundationCompletedPsoriasis | Atopic Dermatitis | AcneUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...PfizerRecruiting
-
Centers for Disease Control and PreventionUniversity of New MexicoCompleted